Growth Metrics

Soleno Therapeutics (SLNO) Profit After Tax Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 65.80%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -129.68%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn 171.68%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 171.68%
Dec 31, 2025 177.51%
Sep 30, 2025 133.95%
Jun 30, 2025 78.46%
Mar 31, 2025 -104.57%
Dec 31, 2024 -395.59%
Sep 30, 2024 -605.42%
Jun 30, 2024 -157.86%
Mar 31, 2024 -156.08%
Dec 31, 2023 -105.91%
Sep 30, 2023 -77.12%
Jun 30, 2023 -26.02%
Mar 31, 2023 -45.98%
Dec 31, 2022 -93.99%
Sep 30, 2022 24.67%
Jun 30, 2022 38.80%
Mar 31, 2022 36.07%
Dec 31, 2021 0.84%
Sep 30, 2021 4.74%
Jun 30, 2021 -48.81%
Mar 31, 2021 -52.85%
Dec 31, 2020 80.50%
Sep 30, 2020 -1,061.19%
Jun 30, 2020 26.22%
Mar 31, 2020 16.67%
Dec 31, 2019 -5,660.84%
Sep 30, 2019 138.50%
Jun 30, 2019 -41.80%
Mar 31, 2019 -84.81%
Dec 31, 2018 103.38%
Sep 30, 2018 7.34%
Jun 30, 2018 -130.96%
Mar 31, 2018 -86.01%
Dec 31, 2017 -448.11%
Sep 30, 2017 -40.24%
Jun 30, 2017 13.01%
Mar 31, 2017 35.87%
Dec 31, 2016 50.02%
Sep 30, 2016 46.04%
Jun 30, 2016 -286.76%
Mar 31, 2016 72.63%
Dec 31, 2015 60.59%
Sep 30, 2015 -37.61%
Jun 30, 2015 167.35%
Mar 31, 2015 -1,297.00%
Dec 31, 2014 -640.95%
Sep 30, 2014 -50.50%